LONDON–(BUSINESS WIRE)–Cell Medica, a leader in developing, marketing and manufacturing cellular therapeutics for cancer and infections, has signed a research collaboration with UCL (University College London) aiming to utilize UCL’s novel T cell receptor (TCR) technology to generate leading-edge modified TCR products for the treatment of cancer. The collaboration also …
Tag Archives: ucl
August, 2016
October, 2015
-
14 October
Takeda and UCL Enter Research Partnership to Identify Novel Target Genes for Neurodegenerative Disease
LONDON & CAMBRIDGE, England–(BUSINESS WIRE)–UCL (University College London) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced a new research collaboration to identify and validate novel target genes for the treatment of neurodegenerative disease. This collaboration will focus on mechanistic approaches for the identification of genes or signalling pathways that modify …
January, 2015
-
22 January
Syncona and UCL Business Form Cancer Immunotherapy Company Autolus
Backed with roughly $45.5 million, Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University College London, have launched the latest CAR T upstart, Autolus Limited. According to the companies, Autolus is a biopharmaceutical company focused on the development and commercialization of next-generation engineered T-cell therapies for …